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Needling the liver: Time of Young Lion
Tadahiro Takada
Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan
Needling the Liver
“This is it! This is wonderful. I have never done treat-
ments that way. I have never even seen it done!”
“Dr. Takada, a resident doctor, did it.”
“That’s wonderful! Dr. Takeda, quickly, write a paper 
on it in English.”
Toward the end of 1972, Professor Nakayama, head 
of the Institute of Gastroenterology, Tokyo Women’s 
Medical University (TWMU), praised the work of a 
young resident doctor to the staff of the Institute. Dr. 
Takada, or Tadahiro Takada, was then 30 years old and 
in his ﬁ  fth year as a resident doctor. He was one of the 
second generation of students who had graduated from 
the Institute of Gastroenterology, TWMU, where Pro-
fessor Nakayama had established a resident system. It 
was uncommon to receive such praise from the founder 
of the Institute whose usual ritual was to lecture.
Professor Nakayama’s praise of Dr. Takada was in 
regard to the technology called percutaneous transhe-
patic cholangio-drainage (PTCD) (also known as per-
cutaneous tranhepatic biliary drainage [PTBD]) that 
Dr. Takada had developed. Professor Nakayama fur-
ther advised Dr. Takada to write a paper on the subject 
in English. In the early 1970s it was rare for Japanese 
surgical doctors to write a paper in English, and there 
had been no such precedent at the Institute. PTCD 
technology would become popular not only in Japan but 
also among doctors the world over.
Upon hearing Professor Nakayama’s praise, Dr. 
Takada was ﬁ  lled with deep emotion. The result of 
years of effort and hard work at the Institute was at last 
recognized. Two years had already passed since Dr. 
Takada ﬁ  rst developed PTCD.
PTCD is used for cases of obstructive jaundice, a 
symptom where the eyes, hands, legs, or the entire body 
is yellowed because the concentration of bilirubin (i.e., 
a pigment in bile) reaches the higher blood levels, due 
I came across a copy of an essay written by 
Professor Tadayoshi Takemoto (Emeritus Professor at 
the Institute of Gastroenterology, Tokyo Women’s 
Medical University [TWMU]) that describes the 
study of endoscopy in the Institute. In that essay he 
mentions my struggle to develop percutaneous transhe-
patic cholangio-drainage (PTCD, or percutaneous 
transhepatic biliary drainage [PTBD]) for treatment of 
obstructive jaundice when I was a resident doctor. At 
that time, we did not have endoscopic retrograde 
cholangiopancreatography (ERCP), not to mention 
sonography, computed tomography (CT), or magnetic 
resonance imagine (MRI); it was difﬁ  cult to diagnose or 
treat jaundice. The essay is a description of a young 
doctor struggling in clinical studies, written from 
the viewpoint of Professor Takemoto as an outside ob-
server. At that time, I was a resident surgical doctor 
at the Institute of Gastroenterology, Tokyo Women’s 
Medical University established by Professor Komei 
Nakayama (who passed away in 2005); Professor 
Takemoto was a professor and chairman of the Depart-
ment of Gastroenterology and also chief of the Gastro-
enterological Endoscopy Department. Professor 
Takemoto has no experience of having worked together 
with me but wrote about my efforts through his great 
insight.
The essay is titled “Needling the Liver,” contained in 
a section called “Children of Endoscopy,” published by 
Professor Takemoto.
Professor Takemoto specialized in endoscopy while 
my research was conducted by X-ray apparatus. I have 
no idea why Professor Takemoto chose my research as 
a topic, since it had little to do with his specialty. At any 
rate, my efforts and struggles were depicted through the 
eyes of Professor Takemoto. I was then in my third year 
as a resident doctor. I make this paper public with a 
view to encouraging young doctors to take up the torch 
during those times when great efforts in clinical studies 
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to the inadequate ﬂ  ow of bile through the duct because 
of biliary calculuses or cancer. If a case of obstructive 
jaundice is left untreated, the patient is likely to suffer 
hepatic dysfunction, renal dysfunction, or bleeding in 
the digestive tract, which leads to death.
Nowadays, it can be easily cured thanks to PTCD. If 
you would like to watch a live treatment with PTCD, 
you may come to the Institute of Gastroenterology, 
TWMU Hospital. There you will see patients walking 
in the hallway wearing hospital gowns and carrying plas-
tic collection bottles ﬁ  lled with dark liquid. Extending 
from the bottles are tubes that connect to the patient to 
drain the bile. Most of these patients are treated with 
PTCD to abate the symptom of jaundice.
PTCD is used on a daily basis. The PTCD treatment 
is to directly stick a long needle into the section of bile 
duct in the liver (hepatic duct) from outside of the body 
and insert a tube to remove bile that is the cause of 
jaundice.
In 1967 when Takada joined the Institute, clinical 
doctors were challenged by how to reduce jaundice. The 
easiest way was a surgical operation; however, it put 
heavy stress on the liver, already under stress from jaun-
dice. Moreover, the mortality rate was as high as about 
30% of patients who had undergone an operation sim-
ply to remove the symptom of jaundice.
Is there any other way?
“When I joined the Institute, I saw a lot of cases of re-
current gastric cancer patients who died, having jaun-
dice and hematemesis with oliguria. I had always wanted 
to alleviate the jaundice in such patients. I think it was 
that desire which led to the idea of percutaneous tran-
shepatic cholangio-drainage (PTCD),” said Dr. Takada 
about his motive for the development of PTCD.
Dr. Takada graduated from the School of Medicine, 
Chiba University. When he was about to ﬁ  nish his in-
ternship at that school, he learned that the Institute of 
Gastroenterology, Tokyo Women’s Medical University 
Hospital, was recruiting resident doctors. He applied 
for the position and was hired by the Institute, where 
patients with recurrent gastric cancer were dying ago-
nizing deaths due to jaundice.
Always thinking of how to safely alleviate the symp-
tom of jaundice without surgical intervention, Dr. Taka-
da heard that doctors at the Department of Surgery I, 
Chiba University, stuck a needle into patients through 
the ﬂ  ank and inserted a pipe to drain bile that had ac-
cumulated in their bodies. He was then in his third year 
as a resident doctor (1970). He asked Dr. Fujio Hanyu, 
then associate professor at the Institute, to write a letter 
to that department requesting that Dr. Takada watch 
the paracentesis being practiced at Chiba University. 
He saw the procedure three times but each time it failed. 
He returned to the Institute of Gastroenterology, 
TWMU, with no further observation, and thought there 
should be other ways.
“That was a totally new invention,” remembered Dr. 
Takada, referring to the percutaneous transhepatic 
cholangiography (PTC) (Fig. 1) that he experienced the 
ﬁ  rst year he joined the Institute (1967). PTC involved 
sticking a thin needle into the ﬂ  ank and hepatic duct 
and injecting a contrast medium, thus enabling more 
precise diagnosis of biliary calculuses or cancers. How-
ever, further study was needed on how to remove the 
symptom of jaundice, and Dr. Takada resolved to do 
this. He heard of, and went to see, the paracentesis at 
Chiba University, but it had not been successful.
Fig. 1.  Practice of percutaneous transhepatic cholangiogra-
phy (PTC). A needle is inserted into the section of the bile 
duct in the liver under ﬂ  uoroscopic monitoring and a contrast 
medium is injected into the biliary tract for cholangiography
Fig. 2.  Performance of percutaneous transhepatic cholangio-
drainage (PTCD) under ﬂ  uoroscopic monitoring (direct ap-
proach). After PTC, a needle is inserted into the intrahepatic 
bile duct from the top of the obtained cholangiogram (along 
the direction of projection of radiations) and a catheter is in-
serted into the intrahepatic bile duct for biliary drainage124  T. Takada: Needling the liver: Time of Young Lion
ment (who passed away in 1993), supported him and 
took responsibility for allowing the use of PTC. Dr. 
Takada was permitted to use it as the ﬁ  rst staff case on 
condition that he would do it jointly with other staff 
members.
It was a success!
As a consequence, work with PTC increased at the In-
stitute and Dr. Takada’s reputation grew. His next push 
was for PTCD. He argued that a needle about 3  mm 
thick could be inserted into the bile duct so accumulated 
bile could be drained out of the body. Once again Dr. 
Takada faced strong opposition within the Institute. 
They were worried that such treatment could kill pa-
tients and refused to allow him to proceed.
With the cooperation of contemporary residents, Dr. 
Takada took a patient to the Radiological Diagnosis 
Room at midnight and performed percutaneous drain-
age from the bile duct on the patient by means of a 
method he had devised and named direct percutaneous 
transhepatic cholangio-drainage under ﬂ  uoroscopic 
monitoring.
When this ﬁ  rst use of the method was a success, the 
atmosphere totally changed at the Institute. He received 
successive requests for drainage, and even during meet-
ings of academic societies, he was sometimes called by 
telephone and had to return to the Institute to perform 
PTCD. Yet he still had to practice diagnosis by means 
of PTCD in the middle of the night, i.e., he conducted 
underground research.
It was not until the spring of 1972 when Dr. Hanyu, 
associate professor at the Institute of Gastroenterology 
(he was the most aggressive surgeon there) called and 
asked him to perform transhepatic drainage on a case 
of acute obstructive suppurative cholangitis (AOSC) 
with shock due to infection in the biliary system that Dr. 
How could it be done?
Dr. Takada thought of inserting a needle through the 
front side of the body instead of the ﬂ  ank (Fig. 2). At 
Chiba University, they X-rayed patients and tried to 
insert a needle through the ﬂ  ank, depending upon the 
contrast medium, but they failed. Two-dimensional im-
ages from the front side do not provide any information 
on the depth in the body. Without information on the 
depth in the body, sticking a needle that is sometimes 
thicker than that for taking images depends largely on 
the surgeon’s instinct. If the surgeon inserts a needle in 
the front side, he can know the position of the bile duct 
in a two-dimensional plane. For the depth in the body, 
he can insert a needle to sufﬁ  ciently exact depths based 
on the data obtained from images of the inside of the 
body.
Then Dr. Takada had an idea, but his main problem 
was how to test it at the Institute of Gastroenterology, 
TWMU University Hospital. His attempts led to a bitter 
experience. Even though he was only in his ﬁ  rst year as 
a resident doctor, he argued that PTC be used to take 
images within the body so that it would be possible to 
check the biliary system, the situation of which was dif-
ﬁ  cult to see and understand. At that time, ultrasonog-
raphy, CT, MRI, and ERCP did not yet exist, so 
obstructive jaundice could be diagnosed only by an ab-
dominal operation or as a result of autopsy. Dr. Takada, 
therefore, dared to propose using PTC. But most of the 
doctors at the Institute were against it, and for reasons 
that are unbelievable based on common knowledge to-
day, namely that the obstructed bile duct was under 
high pressure and could rupture if a contrast medium 
was put in it or bile leaked out of the duct. It was too 
risky, they said. Dr. Takada still continued to advocate 
using PTC. Finally Dr. Seiichiro Kobayashi, associate 
professor and head of the Radiology Research Depart-
Fig. 3.  The ﬁ  rst case in the world of chol-
angitic hepatic abscesses that could be 
diagnosed and treated by means of PTCD. 
When PTC was performed, images of nu-
merous cyst-like shadows in disorderly 
shapes continuing from the hepatic bile 
duct were seen (left). The bile duct in the 
lower section was blocked. Suctioned bile 
was pus. Then biliary drainage was per-
formed by means of PTCD immediatelyT. Takada: Needling the liver: Time of Young Lion  125
then fulltime professor, and ﬁ  nally, professor and chair-
man of the Department of Surgery (Teikyo University 
School of Medicine).
In the early stages, paracentesis in PTCD was per-
formed under X-ray monitoring. Improvements now 
mean it can be performed under ultrasonic monitoring, 
which is used nowadays.
Fig. 4.  Cholangiogram 4 days later, when 
the condition of the whole body had been 
improved. The numerous cyst-like shad-
ows in disorderly shapes continuing from 
the hepatic bile duct that were seen in the 
ﬁ  rst instance of cholangiography were 
much fewer and much smaller in size 
(left). Cholangiography at the time when 
the whole body condition had been com-
pletely improved shows that the cyst-like 
shadows in the liver had completely dis-
appeared and there was only one spot of 
suspended stones in the common bile 
duct
Takada’s technology was publicly recognized. Dr. 
Hanyu had previously operated on some cases of ob-
structive jaundice with AOSC, but all patients had died 
during operation. Dr. Hanyu said he had asked Dr. 
Takada to rise to the challenge, which he did. Dr. Ta-
dahiro Takada succeeded in diagnosing and treating the 
case. Following this successful drainage, he was allowed 
to conduct his own style of treatment at the Institute of 
Gastroenterology, TWMU Hospital.
Toward the end of that year, Dr. Takada’s technology 
attracted Dr. Nakayama’s attention, when Dr. 
Takada presented at a medical conference a serious 
case of cholangitic hepatic abscesses that could have 
been diagnosed only by autopsy but had actually been 
diagnosed and treated clinically by means of PTCD 
(Figs. 3 and 4). Dr. Nakayama listened to his presenta-
tion and advised him to write a paper on PTCD in 
English, whereupon his technology became known 
worldwide.
Being at the bedside of patients with serious jaundice, 
Dr. Takada had searched for a cure for jaundice, and 
after much struggle, developed the percutaneous tran-
shepatic cholangio-drainage (PTCD) technology. The 
fruit of his struggle was ﬁ  nally made known to the world 
thanks to the praise of the renowned Professor Na-
kayama. Dr. Takada was employed as the only fellow 
among the ﬁ  rst and second generation of resident doc-
tors at the Institute; resident doctors at the Institute 
were generally not employed as fellows by Tokyo Wom-
en’s Medical University Hospital, and after 6 years of 
training they had to ﬁ  nd positions at other local hospi-
tals, according to a policy enacted by Professor Na-
kayama, head of the Institute. Only Dr. Takada stayed 
on at TWMU Hospital as a fellow, and he went on to 
become assistant professor, then associate professor, 
Fig. 5.  The ﬁ  rst case of percutaneous transhepatic cholangios-
copy (PTCS) in the world. The arrow shows where the endo-
scope is inserted126  T. Takada: Needling the liver: Time of Young Lion
“Thanks to patients, I arrived at the idea of percuta-
neous transhepatic cholangio-drainage,” Dr. Takada 
said as he remembered the opportunities that led to his 
great leap, one that led him to become an apprentice to 
Professor Nakayama.
In his fourth year as a resident doctor, Dr. Takada 
further developed percutaneous transhepatic cholan-
gio-drainage into percutaneous transhepatic cholan-
gioscopy (PTCS), for the ﬁ  rst time in the world (Figs. 5 
and 6). The endoscope had so far been inserted per-
orally to observe the inside of the body; by contrast, in 
PTCS, it was inserted through an artiﬁ  cial tube inserted 
percutaneously to observe the inside of the bile duct. 
As in endoscopy or ERCP for the digestive tract, once 
there was a technological breakthrough in the ﬁ  eld of 
biliary drainage, various diagnostic or treatment tools 
have developed and medicine advances once again.
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Fig. 6.  The ﬁ  rst case of percutaneous transhepatic bile duct 
biopsy in the world. This is a case of recurrent gastric cancer 
combined with obstructive jaundice. The bile cytology showed 
that it was Class 1 but the result of biopsy exactly revealed the 
existence of cancer cells in tissues under the epithelium of the 
bile duct
Fig. 7.  Biopsied specimen through percutaneous transhepatic 
bile duct biopsy. The membrane of the bile duct was normal; 
however, cancer cells were found in tissues under the mem-
brane of the bile duct 